Agilent Technologies
Market Cap
US$39.0b
Last Updated
2021/01/22 23:08 UTC
Data Sources
Company Financials +
Executive Summary
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet with questionable track record.
Similar Companies
Share Price & News
How has Agilent Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: A is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.
Market Performance
7 Day Return
0.09%
A
2.9%
US Life Sciences
2.3%
US Market
1 Year Return
43.1%
A
51.2%
US Life Sciences
23.7%
US Market
Return vs Industry: A underperformed the US Life Sciences industry which returned 49.8% over the past year.
Return vs Market: A exceeded the US Market which returned 22.6% over the past year.
Shareholder returns
| A | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.09% | 2.9% | 2.3% |
| 30 Day | 7.7% | 10.9% | 4.7% |
| 90 Day | 19.0% | 17.3% | 14.5% |
| 1 Year | 44.3%43.1% | 51.4%51.2% | 26.5%23.7% |
| 3 Year | 73.3%68.8% | 110.7%109.3% | 45.0%35.4% |
| 5 Year | 251.2%235.5% | 250.1%245.6% | 126.2%100.9% |
Long-Term Price Volatility Vs. Market
How volatile is Agilent Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
If You Had Bought Agilent Technologies (NYSE:A) Shares Five Years Ago You'd Have Earned 239% Returns3 weeks ago | Simply Wall St
Is Agilent Technologies, Inc.'s(NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals?1 month ago | Simply Wall St
Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$119?Valuation
Is Agilent Technologies undervalued compared to its fair value and its price relative to the market?
54.29x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: A ($126.33) is trading above our estimate of fair value ($75.17)
Significantly Below Fair Value: A is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A is poor value based on its PE Ratio (54.3x) compared to the US Life Sciences industry average (48.8x).
PE vs Market: A is poor value based on its PE Ratio (54.3x) compared to the US market (21.1x).
Price to Earnings Growth Ratio
PEG Ratio: A is poor value based on its PEG Ratio (3.7x)
Price to Book Ratio
PB vs Industry: A is good value based on its PB Ratio (7.9x) compared to the US Life Sciences industry average (8.7x).
Next Steps
Future Growth
How is Agilent Technologies forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
14.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A's forecast earnings growth (14.7% per year) is above the savings rate (2%).
Earnings vs Market: A's earnings (14.7% per year) are forecast to grow slower than the US market (21.6% per year).
High Growth Earnings: A's earnings are forecast to grow, but not significantly.
Revenue vs Market: A's revenue (6.5% per year) is forecast to grow slower than the US market (10.6% per year).
High Growth Revenue: A's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A's Return on Equity is forecast to be high in 3 years time (25.7%)
Next Steps
Past Performance
How has Agilent Technologies performed over the past 5 years?
15.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A has high quality earnings.
Growing Profit Margin: A's current net profit margins (13.5%) are lower than last year (20.7%).
Past Earnings Growth Analysis
Earnings Trend: A's earnings have grown by 15.2% per year over the past 5 years.
Accelerating Growth: A's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A had negative earnings growth (-32.7%) over the past year, making it difficult to compare to the Life Sciences industry average (30.4%).
Return on Equity
High ROE: A's Return on Equity (14.8%) is considered low.
Next Steps
Financial Health
How is Agilent Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: A's short term assets ($3.4B) exceed its short term liabilities ($1.5B).
Long Term Liabilities: A's short term assets ($3.4B) exceed its long term liabilities ($3.3B).
Debt to Equity History and Analysis
Debt Level: A's debt to equity ratio (48.4%) is considered high.
Reducing Debt: A's debt to equity ratio has increased from 39.8% to 48.4% over the past 5 years.
Debt Coverage: A's debt is well covered by operating cash flow (39%).
Interest Coverage: A's interest payments on its debt are well covered by EBIT (14.9x coverage).
Balance Sheet
Next Steps
Dividend
What is Agilent Technologies's current dividend yield, its reliability and sustainability?
0.61%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A's dividend (0.61%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: A's dividend (0.61%) is low compared to the top 25% of dividend payers in the US market (3.87%).
Stability and Growth of Payments
Stable Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: A is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.8yrs
Average management tenure
CEO
Mike McMullen (59 yo)
5.83yrs
Tenure
US$12,520,566
Compensation
Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD12.52M) is about average for companies of similar size in the US market ($USD10.57M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.83yrs | US$12.52m | 0.099% $ 38.4m | |
| Senior VP & CFO | 2.33yrs | US$4.38m | 0.014% $ 5.4m | |
| Senior VP | 5yrs | US$2.34m | 0.018% $ 7.0m | |
| Senior VP and President of Life Sciences & Applied Markets Group | no data | US$2.90m | 0.035% $ 13.6m | |
| Principal Accounting Officer | 5.67yrs | no data | 0.014% $ 5.6m | |
| CTO & Senior VP | 17.33yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior Vice President of Human Resources & Global Communications | 0.083yr | US$2.21m | 0.026% $ 10.3m | |
| Senior Vice President of Strategy & Corporate Development | no data | no data | no data | |
| Senior Vice President of Global Infrastructure Services | no data | no data | no data | |
| MD of UK & Ireland Operations and VP of Human Resources - Europe | 16yrs | no data | no data | |
| Senior VP and President of Order Fulfillment & Supply Chain | 7.33yrs | US$2.26m | 0.030% $ 11.6m |
5.8yrs
Average Tenure
55yo
Average Age
Experienced Management: A's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.83yrs | US$12.52m | 0.099% $ 38.4m | |
| Independent Director | 20.92yrs | US$331.49k | 0.000040% $ 15.6k | |
| Independent Non-Executive Director | 14.67yrs | US$356.49k | 0.0015% $ 584.5k | |
| Independent Director | 10yrs | US$351.49k | 0.0041% $ 1.6m | |
| Independent Director | 6.33yrs | US$331.49k | 0.0047% $ 1.8m | |
| Independent Director | 2.83yrs | US$341.49k | 0.0029% $ 1.1m | |
| Independent Non-Executive Chairman | 3.83yrs | US$486.49k | 0.022% $ 8.6m | |
| Independent Director | 5.5yrs | US$341.49k | no data | |
| Independent Director | 1.83yrs | US$282.64k | 0.0019% $ 732.6k | |
| Independent Director | 3.5yrs | US$331.49k | no data | |
| Independent Director | 5.33yrs | US$341.49k | 0.0064% $ 2.5m |
5.5yrs
Average Tenure
65yo
Average Age
Experienced Board: A's board of directors are considered experienced (5.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: A insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Agilent Technologies, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Agilent Technologies, Inc.
- Ticker: A
- Exchange: NYSE
- Founded: 1999
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$38.970b
- Shares outstanding: 306.85m
- Website: https://www.agilent.com
Number of Employees
Location
- Agilent Technologies, Inc.
- 5301 Stevens Creek Boulevard
- Santa Clara
- California
- 95051
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| A | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Nov 1999 |
| AG8 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Nov 1999 |
| A * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Nov 1999 |
| 0HAV | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Nov 1999 |
| AG8 | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Nov 1999 |
| A1GI34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 2 REPR 1 SHS UNSPON | BR | BRL | Jan 2020 |
Biography
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/22 23:08 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/10/31 |
| Annual Earnings | 2020/10/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.